Individual and composite study endpoints: separating the wheat from the chaffUMass Center for Clinical and Translational Science Supported Publications
UMMS AffiliationDepartment of Quantitative Health Sciences; Meyers Primary Care Institute; Department of Medicine, Division of Cardiovascular Medicine
Medical Subject Headings*Clinical Trials as Topic; Cost-Benefit Analysis; *Endpoint Determination; Humans; *Outcome Assessment (Health Care); Prospective Studies; *Research Design; Sample Size; Treatment Outcome
AbstractWe provide an overview of the individual and combined clinical endpoints and patient-reported outcomes typically used in clinical trials and prospective epidemiological investigations. We discuss the strengths and limitations associated with the utilization of aggregated study endpoints and surrogate measures of important clinical endpoints and patient-centered outcomes. We hope that the points raised in this overview will lead to the collection of clinically rich, relevant, measurable, and cost-efficient study outcomes.
Related ResourcesLink to Article in PubMed
- UMCCTS funding
Citation InformationRobert J. Goldberg, Joel M. Gore, Bruce A. Barton and Jerry H. Gurwitz. "Individual and composite study endpoints: separating the wheat from the chaff" Vol. 127 Iss. 5 (2014) ISSN: 0002-9343 (Linking)
Available at: http://works.bepress.com/robert_goldberg/392/